JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 48.96
-0.10 (-0.20%)
Apr 16, 2026, 9:29 AM HKT
36.95% (1Y)
| Market Cap | 157.52B +48.5% |
| Revenue (ttm) | 81.73B +26.3% |
| Net Income | 5.98B +29.2% |
| EPS | 1.87 +27.3% |
| Shares Out | 3.21B |
| PE Ratio | 26.24 |
| Forward PE | 20.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,707,322 |
| Average Volume | 7,835,277 |
| Open | 48.88 |
| Previous Close | 49.06 |
| Day's Range | 47.70 - 49.62 |
| 52-Week Range | 34.25 - 71.70 |
| Beta | 1.20 |
| RSI | 46.68 |
| Earnings Date | May 15, 2026 |
About JD Health International
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical in... [Read more]
Industry Pharmaceutical Retailers
Sector Healthcare
Founded 2014
Employees 5,263
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6618
Financial Performance
In 2025, JD Health International's revenue was 73.44 billion, an increase of 26.28% compared to the previous year's 58.16 billion. Earnings were 5.38 billion, an increase of 29.16%.
Financial numbers in CNY Financial Statements